BCA
VRTX icon

Bay Colony Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

Bay Colony Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-2,027
Closed -$919K – 537
2025
Q4 		$919K Buy
2,027
+697
+52% +$300K 0.11% 169
2025
Q3 		$521K Buy
1,330
+90
+7% +$37.6K 0.06% 282
2025
Q2 		$552K Sell
1,240
-87
-7% -$40.1K 0.08% 229
2025
Q1 		$654K Buy
1,327
+275
+26% +$128K 0.1% 194
2024
Q4 		$424K Sell
1,052
-874
-45% -$405K 0.06% 272
2024
Q3 		$896K Buy
1,926
+87
+5% +$41.8K 0.14% 156
2024
Q2 		$862K Buy
1,839
+29
+2% +$12.6K 0.14% 141
2024
Q1 		$757K Buy
1,810
+954
+111% +$403K 0.13% 159
2023
Q4 		$348K Buy
856
+173
+25% +$63.9K 0.07% 254
2023
Q3 		$237K Sell
683
-39
-5% -$13.6K 0.06% 282
2023
Q2 		$254K Sell
722
-20
-3% -$6.74K 0.06% 268
2023
Q1 		$232K Sell
742
-2
-0.3% -$600 0.06% 275
2022
Q4 		$215K Buy
+744
New +$227K 0.06% 315
2022
Q2 		– Sell
-1,612
Closed -$421K – 394
2022
Q1 		$421K Sell
1,612
-257
-14% -$61K 0.1% 198
2021
Q4 		$410K Buy
+1,869
New +$363K 0.12% 209

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Bay Colony Advisors's VRTX Position: Q1 2026 in Review

Bay Colony Advisors sold out of Vertex Pharmaceuticals (VRTX) in Q1 2026, closing a stake of 2,027 shares — an estimated $919K sold.

Bay Colony Advisors first reported a position in VRTX in Q4 2021 and held it in 15 quarters. The position peaked at $919K in Q4 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • Bay Colony Advisors reported no remaining Vertex Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Bay Colony Advisors sold 2,027 Vertex Pharmaceuticals shares in Q1 2026, an estimated $919K.
  • Bay Colony Advisors first reported a position in Vertex Pharmaceuticals in Q4 2021 and held it in 15 quarters.
  • Bay Colony Advisors's Vertex Pharmaceuticals position peaked at $919K in Q4 2025.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on Bay Colony Advisors's 13F filing for Q1 2026, filed 5 May 2026.